Seventh INTERMACS annual report: 15,000 patients and counting
- PMID: 26520247
- DOI: 10.1016/j.healun.2015.10.003
Seventh INTERMACS annual report: 15,000 patients and counting
Abstract
The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry includes >15,000 patients from 158 participating hospitals. Trends in device strategy, patient profile at implant and survival are presented. Risk factors for mortality with continuous-flow pumps are updated, and the major causes/modes of death are presented. The adverse event burden is compared between eras, and health-related quality of life is reviewed. A detailed analysis of outcomes after mechanical circulatory support for ambulatory heart failure is presented. Recent summary data from PediMACS and MedaMACS is included. With the current continuous-flow devices, survival at 1 and 2 years is 80% and 70%, respectively.
Keywords: INTERMACS; advanced heart failure; destination therapy; mechanical support; ventricular assist device.
Copyright © 2015 International Society for Heart and Lung Transplantation. All rights reserved.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
